Here’s What Analysts Are Saying About UnitedHealth Group (UNH)

UnitedHealth Group Incorporated (NYSE:UNH) is one of the top “blue chip” stocks that were suddenly on fire in April. JPMorgan lifted the price target on UnitedHealth Group Incorporated (NYSE:UNH) to $420 from $389 on April 28, reiterating an Overweight rating on the shares. UnitedHealth Group Incorporated (NYSE:UNH) also received a rating update from Goldman Sachs on May 1, with the firm adding the stock to its US Conviction list. Goldman Sachs has a Buy rating on the shares with a price target of $435 and believes that the company is nearing the bottom of its underwriting cycle for Medicare Advantage, which presents 40% of its business. The rating update came as part of the firm’s monthly update.

UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services

In a separate development, UnitedHealth Group Incorporated (NYSE:UNH) was upgraded to Buy from Hold by Erste Group on April 27. The firm told investors that management has raised its forecast for the full year 2026, which “signals confidence in the operational improvement and the strategic initiatives”.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments.

While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.